Quay Steven C
CEO at ATOS; Chairman, President and CEO at NASTECH PHARMACEUTICAL CO INC
- Sold, on record
- $981k
- Dollars the filings state
- Form 4 sales
- 14
- Latest Oct 1, 2013
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ATOSATOSSA THERAPEUTICS, INC.CEO
- NASTECH PHARMACEUTICAL CO INCChairman, President and CEO
Sales by reason
0
Routine
13
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- NASTECH PHARMACEUTICAL CO INC67,502 shares
- ATOS7,265 shares
Shares sold, every Form 4 sale on record.
Timeline
- Oct 1, 2013Plan not stated
Sold 0.2% of their holdings
$41k7,265 shares at $5.66
- Sep 27, 2007Plan not stated
Sold 1.2% of their holdings
$71k5,200 shares at $13.63
- Jul 25, 2007Plan not stated
Sold 1.3% of their holdings
$71k5,800 shares at $12.21
- Jun 7, 2007Plan not stated
Sold 1.4% of their holdings
$71k6,400 shares at $11.08
- Apr 18, 2007Plan not stated
Sold 1.3% of their holdings
$70k5,850 shares at $12.03
- Feb 27, 2007Plan not stated
Sold 1.3% of their holdings
$70k6,130 shares at $11.50
- Jan 25, 2007Plan not stated
Sold 1.1% of their holdings
$71k5,250 shares at $13.44
- Nov 15, 2006Plan not stated
Sold 0.8% of their holdings
$71k3,620 shares at $19.52
- Oct 9, 2006Plan not stated
Sold 1.1% of their holdings
$81k5,175 shares at $15.61
- Aug 8, 2006Plan not stated
Sold 1.2% of their holdings
$81k5,820 shares at $13.87
10 of 14
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Mar 31, 2026 | ATOS | President & CEO | Awarded | 65,000 | 88,038 | SEC | ||
| Jan 20, 2026 | Jan 22, 2026 | ATOS | President & CEO | AwardedStock Options (right to buy) | 950,000 | $0.60 | $570k | 950,000 | SEC |
| Jan 20, 2026 | Jan 22, 2026 | ATOS | President & CEO | Awarded | 325,203 | 339,101 | SEC | ||
| May 21, 2025 | May 22, 2025 | ATOS | President & CEO | Bought | 11,239 | $0.88 | $10k | 13,898 | SEC |
| May 15, 2025 | May 16, 2025 | ATOS | President & CEO | AwardedStock Option (right to buy) | 1.4M | 1.4M | SEC | ||
| Jun 27, 2024 | Jul 1, 2024 | ATOS | President & CEO | AwardedStock Option (right to buy) | 1.8M | 1.8M | SEC | ||
| Mar 2, 2023 | Mar 6, 2023 | ATOS | President & CEO | AwardedStock Option (right to buy) | 1.9M | 1.9M | SEC | ||
| Feb 24, 2022 | Feb 28, 2022 | ATOS | President & CEO | AwardedStock Option (right to buy) | 1.9M | 1.9M | SEC | ||
| May 14, 2021 | May 18, 2021 | ATOS | President & CEO | AwardedStock Option (right to buy) | 1.9M | 1.9M | SEC | ||
| May 14, 2021 | May 18, 2021 | ATOS | President & CEO | AwardedStock Option (right to buy) | 1.9M | 1.9M | SEC | ||
| Apr 9, 2020 | Apr 13, 2020 | ATOS | President & CEO | AwardedStock Option (Right to Buy) | 1.5M | 1.3M | SEC | ||
| Jan 13, 2019 | Jan 15, 2019 | ATOS | President & CEO | Returned to the companyStock Option (Right to Buy) | 2.3M | 0 | SEC | ||
| Jan 13, 2019 | Jan 15, 2019 | ATOS | President & CEO | AwardedStock Option (Right to Buy) | 2.3M | 2.3M | SEC | ||
| Jun 27, 2018 | Jun 29, 2018 | ATOS | President & CEO | AwardedStock Option (right to buy) | 2.3M | 2.3M | SEC | ||
| May 30, 2018 | May 31, 2018 | ATOS | President & CEO | BoughtSeries B Convertible Preferred Stock | 2,280 | $1,000.00 | $2.3M | 2,272 | SEC |
| May 24, 2017 | May 26, 2017 | ATOS | President & CEO | AwardedStock Option (right to buy) | 575,893 | 651,785 | SEC | ||
| May 18, 2016 | May 19, 2016 | ATOS | President & CEO | AwardedCommon Stock (right to buy) | 569,194 | 569,194 | SEC | ||
| Mar 9, 2016 | Mar 10, 2016 | ATOS | President & CEO | Bought | 15,000 | $0.37 | $6k | 4.8M | SEC |
| Feb 16, 2016 | Feb 17, 2016 | ATOS | President & CEO | Bought | 15,000 | $0.53 | $8k | 4.8M | SEC |
| Jan 19, 2016 | Jan 21, 2016 | ATOS | President & CEO | Bought | 50,000 | $0.20 | $10k | 4.8M | SEC |
| Mar 16, 2015 | Mar 18, 2015 | ATOS | President and CEO | AwardedStock Options | 275,000 | 275,000 | SEC | ||
| May 6, 2014 | May 8, 2014 | ATOS | CEO | AwardedStock Option (right to buy) | 250,000 | 250,000 | SEC | ||
| Oct 1, 2013 | Oct 3, 2013 | ATOS | CEO | Sold | 7,265 | $5.66 | $41k | 4.3M | SEC |
| Jul 18, 2013 | Feb 14, 2014 | ATOS | Chief Executive Officer | Gift | 106,000 | 478,543 | SEC | ||
| Mar 11, 2013 | Mar 13, 2013 | ATOS | CEO | AwardedStock Option (right to buy) | 44,194 | 44,194 | SEC | ||
| Mar 20, 2009 | Mar 20, 2009 | NASTECH PHARMACEUTICAL CO INC | Director | Awarded | 731,275 | 1.2M | SEC | ||
| Mar 16, 2009 | Mar 20, 2009 | NASTECH PHARMACEUTICAL CO INC | Director | OtherCommon Stock Options of MDRNA, Inc. | 1.5M | $14.46 | $21.7M | 1.7M | SEC |
| Jun 10, 2008 | Jun 12, 2008 | NASTECH PHARMACEUTICAL CO INC | Chairman and CSO | AwardedMDRNA, Inc. Common Stock Options | 1.7M | $2.84 | $4.8M | 3.2M | SEC |
| Apr 1, 2008 | Apr 2, 2008 | NASTECH PHARMACEUTICAL CO INC | Chairman and CEO | Other | 3,500 | $2.00 | $7k | 434,459 | SEC |
| Sep 27, 2007 | Sep 28, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 5,200 | $13.63 | $71k | 430,959 | SEC |
| Jul 25, 2007 | Jul 27, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 5,800 | $12.21 | $71k | 436,159 | SEC |
| Jul 20, 2007 | Jul 23, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Withheld for tax | 11,103 | $12.61 | $140k | 441,959 | SEC |
| Jun 7, 2007 | Jun 8, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 6,400 | $11.08 | $71k | 453,062 | SEC |
| Apr 18, 2007 | Apr 20, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 5,850 | $12.03 | $70k | 459,462 | SEC |
| Feb 27, 2007 | Mar 1, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 6,130 | $11.50 | $70k | 465,312 | SEC |
| Feb 6, 2007 | Feb 8, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | AwardedNastech Pharmaceutical Company Inc Stock Options | 4,247 | $13.16 | $56k | 1.5M | SEC |
| Jan 25, 2007 | Jan 26, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 5,250 | $13.44 | $71k | 471,442 | SEC |
| Nov 15, 2006 | Nov 17, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 3,620 | $19.52 | $71k | 476,692 | SEC |
| Oct 9, 2006 | Oct 10, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 5,175 | $15.61 | $81k | 480,312 | SEC |
| Aug 8, 2006 | Aug 8, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 5,820 | $13.87 | $81k | 485,487 | SEC |
| Jul 20, 2006 | Jul 21, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Withheld for tax | 11,103 | $12.22 | $136k | 491,307 | SEC |
| Jun 15, 2006 | Jun 15, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 5,540 | $14.57 | $81k | 502,410 | SEC |
| Apr 25, 2006 | Apr 27, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 5,100 | $15.76 | $80k | 507,950 | SEC |
| Apr 11, 2006 | Apr 12, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Exercised or settledNastech Pharmaceutical Company Inc Stock Options | 2,667 | $9.78 | $26k | 0 | SEC |
| Apr 11, 2006 | Apr 12, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 2,667 | $15.83 | $42k | 165 | SEC |
| Apr 11, 2006 | Apr 12, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Exercised options | 2,667 | $9.78 | $26k | 2,832 | SEC |
| Mar 16, 2006 | Mar 17, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Sold | 4,950 | $16.24 | $80k | 513,050 | SEC |
| Feb 1, 2006 | Mar 17, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Returned to the companyNastech Pharmaceutical Company Inc Stock Options | 1,333 | $9.78 | $13k | 2,667 | SEC |
| Feb 1, 2006 | Mar 17, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Returned to the company | 852 | 165 | SEC |
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2013 | Oct 3, 2013 | ATOS | CEO | Form 4 sale | 7,265 | $41k | 0.2% | Plan not stated | SEC |
| Sep 27, 2007 | Sep 28, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 5,200 | $71k | 1.2% | Plan not stated | SEC |
| Jul 25, 2007 | Jul 27, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 5,800 | $71k | 1.3% | Plan not stated | SEC |
| Jun 7, 2007 | Jun 8, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 6,400 | $71k | 1.4% | Plan not stated | SEC |
| Apr 18, 2007 | Apr 20, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 5,850 | $70k | 1.3% | Plan not stated | SEC |
| Feb 27, 2007 | Mar 1, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 6,130 | $70k | 1.3% | Plan not stated | SEC |
| Jan 25, 2007 | Jan 26, 2007 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 5,250 | $71k | 1.1% | Plan not stated | SEC |
| Nov 15, 2006 | Nov 17, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 3,620 | $71k | 0.8% | Plan not stated | SEC |
| Oct 9, 2006 | Oct 10, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 5,175 | $81k | 1.1% | Plan not stated | SEC |
| Aug 8, 2006 | Aug 8, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 5,820 | $81k | 1.2% | Plan not stated | SEC |
| Jun 15, 2006 | Jun 15, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 5,540 | $81k | 1.1% | Plan not stated | SEC |
| Apr 25, 2006 | Apr 27, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 5,100 | $80k | 1.0% | Plan not stated | SEC |
| Apr 11, 2006 | Apr 12, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 2,667 | $42k | 94.2% | Unusual | SEC |
| Mar 16, 2006 | Mar 17, 2006 | NASTECH PHARMACEUTICAL CO INC | Chairman, President and CEO | Form 4 sale | 4,950 | $80k | 1.0% | Plan not stated | SEC |